Sage Rhino Capital LLC Vincerx Pharma, Inc. Call Options Transaction History
Sage Rhino Capital LLC
- $411 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VINC
# of Institutions
39Shares Held
8.46MCall Options Held
0Put Options Held
0-
Octagon Capital Advisors LP New York, NY1MShares$810,0000.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct955KShares$773,4090.01% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$722,2920.12% of portfolio
-
Bank Of America Corp Charlotte, NC701KShares$568,1520.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA667KShares$540,2650.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $17.2M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...